Erqi L. Pollom

Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma

Daniel Wahl, Matthew H. Stenmark, Yebin Tao et al. · Journal of Clinical Oncology · 2015 · 599 citations

Medicine, Oncology, Surgery +17

Second cancer risk after primary cancer treatment with three‐dimensional conformal, intensity‐modulated, or proton beam radiation therapy

Michael Xiang, Daniel T. Chang, Erqi L. Pollom · Cancer · 2020 · 177 citations

Medicine, Oncology, Radiation Oncology +17

Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Ben Y. Durkee, Yushen Qian, Erqi L. Pollom et al. · Journal of Clinical Oncology · 2015 · 118 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Single- versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity

Erqi L. Pollom, Muthuraman Alagappan, Rie von Eyben et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 112 citations

Medicine, Oncology, Radiation Oncology +12

Brain Metastases in EGFR- and ALK-Positive NSCLC: Outcomes of Central Nervous System-Penetrant Tyrosine Kinase Inhibitors Alone Versus in Combination With Radiation

Nicholas J. Thomas, Nathaniel J. Myall, Fangdi Sun et al. · Journal of Thoracic Oncology · 2021 · 112 citations · Full text

Medicine, Oncology, Radiation Oncology +12